Skip to main content

Articles

Original Research
Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis
Jeffrey T. Guptill, MD, MA, MHS; M. Chris Runken, PharmD; Michael Eaddy, PharmD, PhD; Orsolya Lunacsek, PhD; Rupali M. Fuldeore, MS
Stakeholder Perspective
Enhanced Understanding and Management of Rare Diseases Can Reduce Costs, Improve Clinical Outcomes
James T. Kenney, RPh, MBA
Read More
Oncology, Original Research
Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases
Lonnie Wen, RPh, PhD; Adriana Valderrama, PhD; Mary E. Costantino, PhD; Stacey Simmons, MD
Read More
Original Research, Practice Management
Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population
Kathryn Fitch, RN, MEd; Xiaoyun Pan, MS, PhD; Jocelyn Lau, MPH; Tyler Engel, ASA, MAAA; Krithika Rajagopalan, MS, PhD
Read More
FDA Approvals
Tavalisse (Fostamatinib Disodium Hexahydrate) First Spleen Tyrosine Kinase Inhibitor Approved for Chronic Immune Thrombocytopenia
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
Read More
FDA Approvals, In the News
Tibsovo Now FDA Approved as First-Line Treatment for AML with IDH1 Mutation
Read More
FDA Approvals
Daurismo (Glasdegib) Approved, in Combination with Low-Dose Cytarabine, for Newly Diagnosed Acute Myeloid Leukemia in Older Adults or Those Unfit for Intensive Chemotherapy
Read More
FDA Approvals
Talzenna (Talazoparib) New PARP Inhibitor Approved for the Treatment of HER2-Negative Advanced Breast Cancer with Germline BRCA Mutation
Read More
FDA Approvals, In the News
FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma
Read More
Review Article, Dermatology, Original Research
The Challenge of Managing Atopic Dermatitis in the United States
Steven R. Feldman, MD, PhD; Linda S. Cox, MD; Lindsay C. Strowd, MD; Robert A. Gerber, PharmD, MA, MBA; Steven Faulkner, PharmD, MBA; Debra Sierka, PharmD; Timothy W. Smith, BA; Joseph C. Cappelleri, PhD; Mark E. Levenberg, DO
Stakeholder Perspective
Evolving Therapies for Atopic Dermatitis Will Create New Management Challenges
Gary M. Owens, MD
Read More
Page 53 of 244
Results 521 - 530 of 2434